Schedule 13G ownership disclosure
ALX Oncology Holdings, Inc.
Common Stock, par value $0.001 per share · CUSIP: 00166B105
Event date: 2025-10-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Integrated Core Strategies (US) LLC
Shares: 2,730,504.00 · Class: 5.1%
- Millennium Management LLC
Shares: 3,188,196.00 · Class: 6.0%
- Millennium Group Management LLC
Shares: 3,188,196.00 · Class: 6.0%
- Israel A. Englander
Shares: 3,188,196.00 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-101541
- Form type
- SCHEDULE 13G/A
- Filer
- ALX ONCOLOGY HOLDINGS INC
- CIK
- CIK 1810182
- Filed
- Oct 22, 2025
- Reporting period
- Oct 17, 2025
- Description
- Schedule 13G beneficial ownership